Related references
Note: Only part of the references are listed.Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells
A. S. Ribeiro et al.
ONCOGENE (2010)
Histone H3 lysine 4 di-methylation A novel mark for transcriptional fidelity?
Marina Pinskaya et al.
EPIGENETICS (2009)
CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases
Cynthia A. Zahnow
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
Andre Albergaria et al.
BREAST CANCER RESEARCH (2009)
Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo
Anita Milicic et al.
CANCER RESEARCH (2008)
P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle
Yutaka Shimomura et al.
DEVELOPMENT (2008)
Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival
J. Paredes et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
Annabel C. Borley et al.
BREAST CANCER RESEARCH (2008)
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
Ewan Birney et al.
NATURE (2007)
The landscape of histone modifications across 1% of the human genome in five human cell lines
Christoph M. Koch et al.
GENOME RESEARCH (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
β-Catenin regulates P-cadherin expression in mammary basal epithelial cells
Marisa M. Faraldo et al.
FEBS LETTERS (2007)
P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ
Joana Paredes et al.
VIRCHOWS ARCHIV (2007)
P-cadherin expression in breast cancer: a review
Joana Paredes et al.
BREAST CANCER RESEARCH (2007)
Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway
L. N. Cowell et al.
ONCOGENE (2006)
17β-estradiol and tamoxifen stimulate rapid and transient ERK activation in MCF-7 cells via distinct signaling mechanisms
Hasina Visram et al.
CANCER BIOLOGY & THERAPY (2006)
Growth factor receptor interplay and resistance in cancer
Helen E. Jones et al.
ENDOCRINE-RELATED CANCER (2006)
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy
Iain R. Hutcheson et al.
ENDOCRINE-RELATED CANCER (2006)
Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications
J. M. W. Gee et al.
ENDOCRINE-RELATED CANCER (2006)
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome
Jonna Frasor et al.
CANCER RESEARCH (2006)
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas
I Matos et al.
VIRCHOWS ARCHIV (2005)
P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation
J Paredes et al.
CLINICAL CANCER RESEARCH (2005)
Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer
RI Nicholson et al.
ENDOCRINE-RELATED CANCER (2005)
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor α from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line
R Varshochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells
J Paredes et al.
CANCER RESEARCH (2004)
Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes
J Baxter et al.
EMBO JOURNAL (2004)
Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton
M Goodwin et al.
JOURNAL OF MOLECULAR HISTOLOGY (2004)
Expression of the CCAAT/enhancer-binding proteins C/EBPα, C/EBPβ and C/EBPδ in breast cancer:: correlations with clinicopathologic parameters and cell-cycle regulatory proteins
K Milde-Langosch et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
The cadherin-catenin adhesion system in signaling and cancer
M Conacci-Sorrell et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast
J Paredes et al.
VIRCHOWS ARCHIV (2002)
CCAAT/enhancer binding proteins in normal mammary development and breast cancer
CA Zahnow
BREAST CANCER RESEARCH (2002)
Cadherin junctions in mammary tumors
MJ Wheelock et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma
C Gamallo et al.
MODERN PATHOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
